Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31,294,939
-
Number of holders
-
304
-
Total 13F shares, excl. options
-
36,107,785
-
Shares change
-
+552,030
-
Total reported value, excl. options
-
$3,954,476,972
-
Value change
-
+$63,168,795
-
Put/Call ratio
-
86%
-
Number of buys
-
164
-
Number of sells
-
-114
-
Price
-
$109.51
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q4 2023
342 filings reported holding CNMD - CONMED Corp - Common Stock as of Q4 2023.
CONMED Corp - Common Stock (CNMD) has 304 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36,107,785 shares
.
Largest 10 shareholders include BlackRock Inc. (5,031,016 shares), VANGUARD GROUP INC (3,420,011 shares), Capital Research Global Investors (2,757,108 shares), EARNEST PARTNERS LLC (2,345,697 shares), STATE STREET CORP (1,187,053 shares), BANK OF AMERICA CORP /DE/ (991,750 shares), AMERIPRISE FINANCIAL INC (958,677 shares), Champlain Investment Partners, LLC (957,325 shares), LOOMIS SAYLES & CO L P (811,601 shares), and MACQUARIE GROUP LTD (745,387 shares).
This table shows the top 304 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.